Sensible Biotechnologies

What do we do?

Sensible Biotechnologies is changing the manufacturing paradigm for messenger RNA. The company is led by a young and dynamic team, is financed by world’s top biotech and tech investors, YCombinator the US-based Biomedical Advanced Research and Development Authority-supported accelerator, and supported by the global bio-manufacturing and synthetic biology experts and life science business leaders.

The Sensible Bio Platform
mRNA is typically made via cell-free methods. By leveraging processes in engineered living cells, we produce high-quality mRNA in a cost-efficient and scalable fashion.

• long mRNA opens the path towards novel mRNA-based modalities

• naturally modified mRNA increases the efficacy of mRNA therapies

• cost-effective mRNA manufacturing improves access to mRNA technology

• scalable mRNA production strengthens biosecurity and supply chain resilience

We are combining principles of cell engineering, computational biology and precision fermentation to build the cell-based platform for the manufacturing and design of mRNA vaccines and therapeutics.